Literature DB >> 17276954

Enhancement of ultrasound contrast agent in high-intensity focused ultrasound ablation.

Wen Luo1, Xiaodong Zhou, Xue Tian, Xialong Ren, Minjuan Zheng, Kejun Gu, Guangbin He.   

Abstract

High-intensity focused ultrasound (HIFU) is becoming an increasingly attractive modality for ablation. Enhancement of HIFU is an important issue that has been discussed and investigated worldwide. Ultrasound contrast agents are considered to constitute an efficient medium for changing acoustic characteristics and improving energy deposition in the focal region. The role of microbubbles in inducing enhanced heating, cavitation, and other related events in HIFU ablation has been investigated, with the goal of improving coagulation necrosis volume or decreasing acoustic power and exposure duration. Consequently, with the use of ultrasound contrast agents, applications of HIFU are expected to become more efficient, safe, and accurate and to produce fewer adverse effects. This paper reviews studies that have been conducted to investigate the enhancement of ultrasound contrast agents in HIFU ablation through experiments that were carried out in vitro and in vivo; an analysis of results of this enhancement mechanism is provided.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17276954     DOI: 10.1007/bf02850207

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  9 in total

1.  Production of uniformly sized serum albumin and dextrose microbubbles.

Authors:  Michael J Borrelli; William D O'Brien; Laura J Bernock; Heather R Williams; Eric Hamilton; Jonah Wu; Michael L Oelze; William C Culp
Journal:  Ultrason Sonochem       Date:  2011-05-27       Impact factor: 7.491

2.  Enhanced cavitation by using two consecutive ultrasound waves at different frequencies.

Authors:  Xinmai Yang; Janggun Jo
Journal:  Appl Phys Lett       Date:  2014-11-13       Impact factor: 3.791

3.  Laser-enhanced cavitation during high intensity focused ultrasound: An in vivo study.

Authors:  Huizhong Cui; Ti Zhang; Xinmai Yang
Journal:  Appl Phys Lett       Date:  2013-04-03       Impact factor: 3.791

4.  Non-thermal ablation of rabbit liver VX2 tumor by pulsed high intensity focused ultrasound with ultrasound contrast agent: Pathological characteristics.

Authors:  Cheng-Wen Zhou; Fa-Qi Li; Yan Qin; Chun-Mei Liu; Xiao-Lin Zheng; Zhi-Biao Wang
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

5.  Gas-filled phospholipid nanoparticles conjugated with gadolinium play a role as a potential theragnostics for MR-guided HIFU ablation.

Authors:  Se-Young Choi; Young-Sun Kim; Yeong-Ju Seo; Jehoon Yang; Kyu-Sil Choi
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

6.  Comparison of the synergistic effect of lipid nanobubbles and SonoVue microbubbles for high intensity focused ultrasound thermal ablation of tumors.

Authors:  Yuanzhi Yao; Ke Yang; Yang Cao; Xuan Zhou; Jinshun Xu; Jianxin Liu; Qi Wang; Zhigang Wang; Dong Wang
Journal:  PeerJ       Date:  2016-02-22       Impact factor: 2.984

7.  Nanoparticles Formed by Acoustic Destruction of Microbubbles and Their Utilization for Imaging and Effects on Therapy by High Intensity Focused Ultrasound.

Authors:  Nicholas T Blum; Adem Yildirim; Rajarshi Chattaraj; Andrew P Goodwin
Journal:  Theranostics       Date:  2017-01-15       Impact factor: 11.556

8.  Enhanced thermal effect using magnetic nano-particles during high-intensity focused ultrasound.

Authors:  Surendra Balaji Devarakonda; Matthew R Myers; Dushyanth Giridhar; Seyed Ahmad Reza Dibaji; Rupak Kumar Banerjee
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

9.  High-intensity focused ultrasound-triggered nanoscale bubble-generating liposomes for efficient and safe tumor ablation under photoacoustic imaging monitoring.

Authors:  Gang Feng; Lan Hao; Chunyan Xu; Haitao Ran; Yuanyi Zheng; Pan Li; Yang Cao; Qi Wang; Jizhu Xia; Zhigang Wang
Journal:  Int J Nanomedicine       Date:  2017-06-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.